发明名称 Carbamoyl tetrahydropyridine derivatives
摘要 Carbamoyl tetrahydropyridine derivatives represented by the formula: [in the formula, R<SUP>1 </SUP>and R<SUP>2 </SUP>are identical or different, and each represents a hydrogen atom, a C<SUB>1</SUB>-C<SUB>5 </SUB>alkyl group, or the like; Y<SUP>1</SUP>-Y<SUP>2 </SUP>represents (R<SUP>4</SUP>)C-C(R<SUP>5</SUP>), (R<SUP>6</SUP>)C-N, N-N, (R<SUP>7</SUP>) N-CO, or N-C(R<SUP>8</SUP>); X<SUP>1</SUP>, X<SUP>2</SUP>, and X<SUP>3 </SUP>are identical or different, and each represents a hydrogen atom, a halogen atom, or the like; R<SUP>3</SUP>, R<SUP>4</SUP>, R<SUP>5</SUP>, and R<SUP>6 </SUP>are identical or different, and each represents a hydrogen atom or an alkyl group; R<SUP>7 </SUP>represents a hydrogen atom, a C<SUB>1</SUB>-C<SUB>5 </SUB>alkyl group, or the like; and R<SUP>8 </SUP>represents a hydrogen atom or a carbamoyl group] or a pharmaceutically acceptable salt thereof, and intermediates for the preparation thereof are provided. The derivatives described above are effective for diseases which are believed to involve CRF.
申请公布号 US6894168(B2) 申请公布日期 2005.05.17
申请号 US20030347288 申请日期 2003.01.21
申请人 TAISHO PHARMACEUTICAL CO., LTD. 发明人 NAKAZATO ATSURO;OKUBO TAKETOSHI;KUMAGAI TOSHIHITO;TOMISAWA KAZUYUKI
分类号 A61K31/519;A61P1/00;A61P7/10;A61P9/10;A61P9/12;A61P17/02;A61P25/08;A61P25/16;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P29/00;A61P37/02;A61P43/00;C07D473/00;C07D487/04;(IPC1-7):C07D211/78 主分类号 A61K31/519
代理机构 代理人
主权项
地址